Pα+ Psychedelic Bulletin #162: EQUULUS Therapeutics Emerges from Stealth; Responses to ICER’s Draft Evidence Report on Lykos’ MDMA; and more…
EQUULUS Therapeutics Emerges from Stealth with Non-Hallucinogenic Ibogaine Analog as Lead Candidate • Responses to ICER’s Draft Evidence Report on Lykos’ MDMA-Assisted Psychotherapy for PTSD • Update on Health Canada’s Special Access Program • Beckley Psytech Publishes Phase I Study of Intranasal 5-MeO-DMT • and more…